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Table 1. Step count across different dipper categories for systolic and diastolic blood 
pressure dipping
Step  
counta
Reverse  
dippers Nondippers Dippers
Extreme  
dippers
P for 
trend
1 4,460 ± 1,960 6,760 ± 2,960 8,960 ± 3,540 7,910 ± 3,740 0.023
2 4,740 ± 1,880 6,350 ± 2,530 8,740 ± 3,880 8,250 ± 3,620 0.007
Data are presented as means ± standard deviation.
a1: dipping categories based on systolic blood pressure dipping. 2: dipping categories based 
on diastolic pressure dipping.
To the Editor: We appreciate the 
interest of Dr Sobiczewski and Dr 
Wirtwein in our study “Step Count 
is Associated With Lower Nighttime 
Systolic Blood Pressure and Increased 
Dipping.”1 This study, which included 
patients referred for ambulatory 
blood pressure (ABP) monitoring, 
shows that step count is associated 
with lower nighttime systolic blood 
pressures (BP) and increased systolic 
and diastolic BP dipping. In a second-
ary analysis, we showed that the step 
count increases from reverse dippers 
to extreme dippers using mean BP 
to categorize the participants’ dip-
ping status. It is true that most clini-
cal trials on the prognostic value of 
BP dipping have focused on systolic 
BP rather than mean or diastolic BP 
because, with age, there is a gradual 
shift from diastolic BP to systolic BP 
as predictors of coronary heart dis-
ease.2 In our study, which included 
young to elderly participants, replac-
ing mean BP dipping by systolic or 
diastolic BP dipping to categorize dip-
ping status did not change the associa-
tion between step count and dipping 
categories (Table 1).
It is true that ABP is not necessary 
to diagnose hypertension according 
to European Society of Hypertension 
guidelines. However, this is essentially 
for practical reasons: cost and avail-
ability. The prognosis value of ABP is 
undoubtedly more accurate than office 
BP,3,4 and some of the latest guidelines, 
such as those of the National Institute 
for Health and Clinical Excellence 
(NICE), have recommended a wider 
use of ABP.5 In this regard, we would 
like to emphasize that the prevalence 
of white coat hypertension and masked 
hypertension in our participants with-
out antihypertensive treatment was 22% 
and 27%, respectively. Misclassifying 
patients may result in unnecessary 
treatments or failure to treat patients 
at risk.
Data about secondary hypertension 
or the timing of drug taking, which are 
known to affect BP dipping, were not 
recorded in this study. An influence of 
these variables on BP dipping can there-
fore not be excluded. Blockers of the 
renin angiotensin system, beta- blockers, 
calcium channel blockers, and diuretics 
were not associated with BP dipping. 
However, the study was not designed to 
answer this specific question and may 
therefore not be sufficiently powered to 
resolve this issue.
DiSCLoSURe
The authors declared no conflict of 
interest.
RefeReNCeS
 1. Wuerzner G, Bochud M, Zweiacker C, 
Tremblay S, Pruijm M, Burnier M. Step count 
is associated with lower nighttime systolic 
blood pressure and increased dipping. Am J 
Hypertens 2013; 26:527–534.
 2. Franklin SS, Larson MG, Khan SA, Wong ND, 
Leip EP, Kannel WB, Levy D. Does the rela-
tion of blood pressure to coronary heart dis-
ease risk change with aging? The Framingham 
Heart Study. Circulation 2001; 103:1245–1249.
 3. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins 
N, McClory S, Den Hond E, McCormack P, 
Staessen JA, O’Brien E. Superiority of ambula-
tory over clinic blood pressure measurement 
in predicting mortality: the Dublin Outcome 
Study. Hypertension 2005; 46:156–161.
 4. Sega R, Facchetti R, Bombelli M, Cesana G, 
Corrao G, Grassi G, Mancia G. Prognostic 
value of ambulatory and home blood pres-
sures compared with office blood pressure in 
the general population: follow-up results from 
the Pressioni Arteriose Monitorate e Loro 
Associazioni (PAMELA) Study. Circulation 
2005; 111:1777–1783.
 5. Krause T, Lovibond K, Caulfield M, 
McCormack T, Williams B. Management of 
hypertension: summary of NICE guidance. 
BMJ 2011; 343:d4891.
